NK Cell Therapy Global Market 2018 Top Key Players – Chipscreen Biosciences (China) , Affimed NV (Netherlands) , Altor BioScience Corporation (USA) , Innate Pharma SA (France) , Takeda Pharmaceutical (Japan) , Sorrento Therapeutics Inc. (USA) , Na

Global NK Cell Therapy Market

WiseGuyRerports.com Presents “Global NK Cell Therapy Market Insights, Forecast to 2025” New Document to its Studies Database. The Report Contain 119 Pages With Detailed Analysis.

Description

This report studies the global market size of NK Cell Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of NK Cell Therapy in these regions. 

This research report categorizes the global NK Cell Therapy market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global NK Cell Therapy market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the NK Cell Therapy market based on company, product type, application and key regions.

Get sample Report @ https://www.wiseguyreports.com/sample-request/3444216-global-nk-cell-therapy-market-insights-forecast-to-2025

The various contributors involved in the value chain of NK Cell Therapy include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the NK Cell Therapy include 
Chipscreen Biosciences (China) 
Affimed NV (Netherlands) 
Altor BioScience Corporation (USA) 
Innate Pharma SA (France) 
Takeda Pharmaceutical (Japan) 
Sorrento Therapeutics Inc. (USA) 
NantKwest Inc. (USA) 
Bristol-Myers Squibb (USA) 
NKT Therapeutics (USA)

Market Size Split by Type 
Mogamulizumab 
Lorvotuzumab Mertansine 
Others 
Market Size Split by Application 
Cancer 
Cardiovascular Diseases 
Others

Market size split by Region 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 
Japan 
South Korea 
Australia 
Indonesia 
Singapore 
Malaysia 
Philippines 
Thailand 
Vietnam 
Europe 
Germany 
France 
UK 
Italy 
Spain 
Russia 
Central & South America 
Brazil 
Rest of Central & South America 
Middle East & Africa 
GCC Countries 
Turkey 
Egypt 
South Africa

Complete Report Details @ https://www.wiseguyreports.com/reports/3444216-global-nk-cell-therapy-market-insights-forecast-to-2025

 

Table of Contents -Major Key Points

1 Study Coverage 
1.1 NK Cell Therapy Product 
1.2 Key Market Segments 
1.3 Key Manufacturers Covered 
1.4 Market by Type 
1.4.1 Global NK Cell Therapy Market Size Growth Rate by Type 
1.4.2 Mogamulizumab 
1.4.3 Lorvotuzumab Mertansine 
1.4.4 Others 
1.5 Market by Application 
1.5.1 Global NK Cell Therapy Market Size Growth Rate by Application 
1.5.2 Cancer 
1.5.3 Cardiovascular Diseases 
1.5.4 Others 
1.6 Study Objectives 
1.7 Years Considered

………………

11 Company Profiles 
11.1 Chipscreen Biosciences (China) 
11.1.1 Chipscreen Biosciences (China) Company Details 
11.1.2 Company Description 
11.1.3 Sales, Revenue and Gross Margin of NK Cell Therapy 
11.1.4 NK Cell Therapy Product Description 
11.1.5 Recent Development 
11.2 Affimed NV (Netherlands) 
11.2.1 Affimed NV (Netherlands) Company Details 
11.2.2 Company Description 
11.2.3 Sales, Revenue and Gross Margin of NK Cell Therapy 
11.2.4 NK Cell Therapy Product Description 
11.2.5 Recent Development 
11.3 Altor BioScience Corporation (USA) 
11.3.1 Altor BioScience Corporation (USA) Company Details 
11.3.2 Company Description 
11.3.3 Sales, Revenue and Gross Margin of NK Cell Therapy 
11.3.4 NK Cell Therapy Product Description 
11.3.5 Recent Development 
11.4 Innate Pharma SA (France) 
11.4.1 Innate Pharma SA (France) Company Details 
11.4.2 Company Description 
11.4.3 Sales, Revenue and Gross Margin of NK Cell Therapy 
11.4.4 NK Cell Therapy Product Description 
11.4.5 Recent Development 
11.5 Takeda Pharmaceutical (Japan) 
11.5.1 Takeda Pharmaceutical (Japan) Company Details 
11.5.2 Company Description 
11.5.3 Sales, Revenue and Gross Margin of NK Cell Therapy 
11.5.4 NK Cell Therapy Product Description 
11.5.5 Recent Development 
11.6 Sorrento Therapeutics Inc. (USA) 
11.6.1 Sorrento Therapeutics Inc. (USA) Company Details 
11.6.2 Company Description 
11.6.3 Sales, Revenue and Gross Margin of NK Cell Therapy 
11.6.4 NK Cell Therapy Product Description 
11.6.5 Recent Development 
11.7 NantKwest Inc. (USA) 
11.7.1 NantKwest Inc. (USA) Company Details 
11.7.2 Company Description 
11.7.3 Sales, Revenue and Gross Margin of NK Cell Therapy 
11.7.4 NK Cell Therapy Product Description 
11.7.5 Recent Development 
11.8 Bristol-Myers Squibb (USA) 
11.8.1 Bristol-Myers Squibb (USA) Company Details 
11.8.2 Company Description 
11.8.3 Sales, Revenue and Gross Margin of NK Cell Therapy 
11.8.4 NK Cell Therapy Product Description 
11.8.5 Recent Development 

………..CONTINUED

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industry research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)        

This release was published on openPR.